News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

DFine Announces First Commercial Cases With STAR™ Tumor Ablation System in Europe


10/9/2013 9:47:36 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

SAN JOSE, Calif.--(BUSINESS WIRE)--DFINE, Inc., a fast-growing market leader in the treatment of spinal diseases, today announced the completion of the first European commercial cases with the STARâ„¢ Tumor Ablation System for the palliative treatment of painful metastatic spinal tumors since the device received CE Mark approval last month.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com


comments powered by Disqus
DFine
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES